Comment on

• Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss.

  Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, McDonald WI, Miller DH. Davie CA, et al. Brain. 1995 Dec;118 ( Pt 6):1583-92. doi: 10.1093/brain/118.6.1583. Brain. 1995. PMID: 8595487
• The role of magnetic resonance techniques in understanding and managing multiple sclerosis.

  Miller DH, Grossman RI, Reingold SC, McFarland HF. Miller DH, et al. Brain. 1998 Jan;121 ( Pt 1):3-24. doi: 10.1093/brain/121.1.3. Brain. 1998. PMID: 9549485 Review.
• The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

  O'Riordan JI, Thompson AJ, Kingsley DP, MacManus DG, Kendall BE, Rudge P, McDonald WI, Miller DH. O'Riordan JI, et al. Brain. 1998 Mar;121 ( Pt 3):495-503. doi: 10.1093/brain/121.3.495. Brain. 1998. PMID: 9549525
• MRI: measure of efficacy.

  Ebers G. Ebers G. Brain. 2000 Nov;123 ( Pt 11):2187-8. doi: 10.1093/brain/123.11.2187. Brain. 2000. PMID: 11050019 Review. No abstract available.
• The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

  Molyneux PD, Kappos L, Polman C, Pozzilli C, Barkhof F, Filippi M, Yousry T, Hahn D, Wagner K, Ghazi M, Beckmann K, Dahlke F, Losseff N, Barker GJ, Thompson AJ, Miller DH. Molyneux PD, et al. Brain. 2000 Nov;123 ( Pt 11):2256-63. doi: 10.1093/brain/123.11.2256. Brain. 2000. PMID: 11050025 Clinical Trial.
• Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis.

  Reddy H, Narayanan S, Arnoutelis R, Jenkinson M, Antel J, Matthews PM, Arnold DL. Reddy H, et al. Brain. 2000 Nov;123 ( Pt 11):2314-20. doi: 10.1093/brain/123.11.2314. Brain. 2000. PMID: 11050031
• The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

  Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R. Banati RB, et al. Brain. 2000 Nov;123 ( Pt 11):2321-37. doi: 10.1093/brain/123.11.2321. Brain. 2000. PMID: 11050032